Directori de persones
Juan Antonio Schoenenberger Arnaiz

Juan Antonio Schoenenberger Arnaiz

Grau: Doctor/a

973 705 220
jas.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/B-5701-2009

Grups

Publicacions

  • Antoni Schoenenberger-Arnaiz, Joan; Solanilla-Puertolas, M; Acer-Puig, M; Gomez-Arbones, J

    Informing primary care physicians of patients' involvement in clinical trials carried out at a specialist care level

    Open Access Journal Of Clinical Trials 9 59-64. .

    [doi:10.2147/OAJCT.S134555]

  • Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF

    Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study

    Lung 193 993-1000. .

    [doi:10.1007/s00408-015-9807-6]

  • SCHOENENBERGER ARNAIZ, JUAN ANTONIO

    THERAPEUTIC DRUG MONITORING OF DARUNAVIR IN TWO DIFFERENT TREATMENT MODALITIES

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY 135-135. .

    [doi:10.1136/ejhpharm-2013-000276.373]

  • Milara J; Outeda-Macias M; Aumente-Rubio MD; Más-Serrano P; Aldaz A; Calvo MV; García-Simón MS; Martin-Barbero M; Padullés-Zamora N; Schoenenberger JA; Saavedra-Aldrich M; Tévar-Alfonso E; Saval A; Pastor-Clerigues A; García M; Margusino-Framiñan L; Montero-Alvarez JL; Merino E; Herrero JI; Beunza M; Conesa-Zamora P; Gimenez-Manzorro A; Comas-Sugrañes D; Cano-Marron M; Jiménez-Mutiloa E; Díaz-Ruíz P; Cortijo J

    PEG-Interferon-a ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study.

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 39 29-43. .

    [doi:10.7399/fh.2015.39.1.8547]

  • Rius, J.; Zapata, A.; Ahmad, F.; Schoeneneberger, J.A.

    Use of a pharmacotherapeutic reconciliation process based on "STOPP" criteria applied to patients older than 70 years old admitted in the hospital

    Circular Farmaceutica 73 13-18. .

  • Aragonès-Eroles AM; Puig-Ganau T; Cano-Marron SM; Schoenenberger-Arnaiz JA

    Usefulness of plasma lopinavir levels during pregnancy

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 31 699-700. .

    [doi:10.1016/j.eimc.2013.03.015]

  • Berlana, D.; Sabin, P.; Gimeno-Ballester, V.; Romero-Jiménez, R.; Zapata-Rojas, A.; Marquez, E.; Martínez-Cutillas, J.; Schoenenberger-Arnaiz, J.A.

    Cost analysis of adult parenteral nutrition systems; three-compartment bag versus customized

    NUTRICION HOSPITALARIA 28 2135-2141. .

    [doi:10.3305/nh.2013.28.6.6862]

  • Schoenenberger, Joan A.; Aragones, Ana M.; Cano, Santiago M.; Puig, Teresa; Castello, Angela; Gomez-Arbones, Xavier; Porcel, Jose M.

    The Advantages of Therapeutic Drug Monitoring in Patients Receiving Antiretroviral Treatment and Experiencing Medication-Related Problems

    THERAPEUTIC DRUG MONITORING 35 71-77. .

    [doi:10.1097/FTD.0b013e3182791f8c]

  • Gorgas Torner, M.Q.; Pez Vives, F.; Camós Ramió, J.; De Puig Cabrera, E.; Jolonch Santasusagna, P.; Homs Peipoch, E.; Schoenenberger Arnaiz, J.A.; Codina Jané, C.; Gómez-Arbonés, J.

    Programa de atención farmacéutica integrada en pacientes con enfermedades crónicas.

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 36 229-239. .

    [doi:10.1016/j.farma.2011.06.015]

  • Juan Antonio, Schoenenberger Arnaiz

    PHARMACEUTICAL CARE FOR OUTPATIENTS: THE NEW FRONTIER FOR THE HOSPITAL CLINICAL PHARMACIST

    ATENCION FARMACEUTICA 14 147-149. .

  • Schoenenberger, J.A.; Rumi, L.; Iba~nez, F.; Moroba, A.; Figueras, A.; Mart'inez, M.; Castell'o, A.

    Assessment of the information on investigational oral treatment provided to patients in clinical trials

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY 19 230-231. .

    [doi:10.1136/ejhpharm-2012-000074.380]

  • Olmo, M.; Mart'inez, M.; Castell'o, A.; Ahmad, F.; Mangues, I.; Schoenenberger, J.A.

    Lenalidomide: safety and clinical benefittextdagger

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY 19 235-235. .

    [doi:10.1136/ejhpharm-2012-000074.394]

Projectes

  • DURADA OPTIMA DEL TRACTAMENT ANTIBIOTIC EN PACIENTS AMB VESSAMENT PLEURAL PARAPNEUMONIC COMPLICAT O EMPIEMA: ASSAIG CLINIC RANDOMITZAT
  • MULTINUTRIENT MAIZE: MULTIVITAMIN AND MULTIMINERAL FORTIFIED MAIZE FOR FOOD SECURITY
  • APLICACIO DE LA DETERMINACIO DE NIVELLS PLASMATICS D'ANTIRETROVIRALS A LA DETECCIO DE PROBLEMES RELACIONATS AMB LA MEDICACIO (PRM) EN PACIENTS EN TRACTAMENT PER A LA INFECCIO PER HIV